SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-18-017775
Filing Date
2018-12-24
Accepted
2018-12-21 21:54:32
Documents
82
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-K rasp-20180930.htm   iXBRL 10-K 2367123
2 GRAPHIC img1f3pkiovwot08184488.jpg GRAPHIC 33291
3 GRAPHIC imgjeurxwppwaz08184490.jpg GRAPHIC 15253
4 GRAPHIC imgn3jh2voxnm308184488.jpg GRAPHIC 33958
10 EXHIBIT 21 ex21_1.htm EX-21 1779
11 EXHIBIT 24 ex24_2.htm EX-24 23895
12 EXHIBIT 31.1 ex311_3.htm EX-31.1 18998
13 EXHIBIT 31.2 ex312_4.htm EX-31.2 18526
14 EXHIBIT 32.1 ex321_5.htm EX-32.1 10944
15 EXHIBIT 32.2 ex322_6.htm EX-32.2 12007
  Complete submission text file 0001213900-18-017775.txt   9467487

Data Files

Seq Description Document Type Size
5 DEFINITION rasp-20180930_def.xml EX-101.DEF 308055
6 PRESENTATION rasp-20180930_pre.xml EX-101.PRE 531441
7 CALCULATION rasp-20180930_cal.xml EX-101.CAL 63542
8 LABEL rasp-20180930_lab.xml EX-101.LAB 1027936
9 SCHEMA rasp-20180930.xsd EX-101.SCH 60443
16 EXTRACTED XBRL INSTANCE DOCUMENT rasp-20180930_htm.xml XML 1411928
Mailing Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170 646-396-4087
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-191083 | Film No.: 181251126
SIC: 2834 Pharmaceutical Preparations